Medtech Company Filterlex Receives 2.1 Million Euros EU Grant

Filterlex develops an embolic protection device intended to reduce the risk of stroke and other complications during catheter-based heart procedures

 

Israel-based medical device startup Filterlex Medical Ltd. was awarded a 2.1 million euros (approximately $2.3 million) grant from Horizon 2020, the European Union’s research and innovation program, the company announced last week.

 

Founded in 2015 and based in the northern Israeli town of Yokneam, Filterlex develops an embolic protection device intended to reduce the risk of stroke and other complications during catheter-based heart procedures. The company intends to use the funding for clinical trials.

Filterlex XEO Sigal Eli. Photo: Sharon Bentovצילום: שרון בנטוב Sharon Bentov

Israel has been a partner in the Horizon program, launched in 1984, for the past 23 years. In Israel, the program is carried out by the Israel Innovation Authority (IIA), the government’s tech investment arm, through the Israel-Europe Research and Development Directorate (ISERD).